Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The increase of sVEGFR-1 causes a parallel decrease of maternal plasma concentrations of PlGF in preeclampsia.
“The increase of sVEGFR-1 causes a parallel decrease of maternal plasma concentrations of PIGF in preeclampsia(119, 143–150).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 121 · Cited by 163
Research works printed but not linked: 2
- Fisher KA, Luger A, Spargo BH, Lindheimer MD. Hypertension in preg- nancy: clinical-pathological correlations and remote prognosis. Medicine (Baltimore). 1981;60:267-276.
- Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323:1213-1217.
- Authors
- Karumanchi, S. A.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Karumanchi, S. Ananth
- Venue
- Hypertension
- Published
- 2016-06
- Volume
- 67
- Issue
- 6
- Pages
- 1072-1079
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2341980020
- Cited by
- 163
- References
- 121
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 13 · 2023: 13 · 2022: 23 · 2021: 18 · 2020: 14 · 2019: 20 · 2018: 23 · 2017: 13 · 2016: 1
- FWCI
- 24.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Psychiatry and Mental health › Neurological Complications and Syndromes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- preeclampsia, angiogenic factors, angiogenesis, vascular endothelial growth factor, soluble fms-like tyrosine kinase-1, soluble endoglin, soluble thrombomodulin, endothelial dysfunction
- MeSH terms
- Endoglin, Placenta Growth Factor, Animals, Female, Humans, Neovascularization, Pathologic, Placenta, Pre-Eclampsia, Pregnancy, Prognosis, Biomarkers, Gene Expression Profiling, Vascular Endothelial Growth Factor Receptor-1, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
